Stock ScreenerStock IdeasHigh Risk, High RewardHigh Risk, High Reward StocksSpeculative companies with the highest upside potential according to WallStreet analysts. Proceed with extreme caution!
Stock ScreenerStock IdeasHigh Risk, High Reward
Consensus: Strong Buy + 1 more
Analysts: >= 2
Upside/Downside: >= 500%
| Ticker | Company | Country | Market Cap | Shares | Institutional % | Insider % | Net Insider (L12M) | Net Insider (L3M) |
|---|---|---|---|---|---|---|---|---|
| INTZ | INTRUSION INC | United States | $3.48M | 1,944,675 | 9.22% | 90.78% | Net Buying | Net Buying |
| CLDI | CALIDI BIOTHERAPEUTICS INC | United States | $5.62M | 35,538,034 | 5.35% | 49.17% | Net Selling | Net Buying |
| PPBT | PURPLE BIOTECH LTD | Israel | $10.18M | 198,386,080 | 1.23% | 0.00% | ||
| ASLN | ASLAN PHARMACEUTICALS LTD | Singapore | $8.27M | 439,926,480 | 0.79% | 0.00% | ||
| IQ | IQIYI INC | China | $4.63B | 6,716,137,085 | 4.53% | 0.00% | ||
| CLNN | CLENE INC | United States | $43.28M | 128,430,098 | 9.06% | 52.75% | Net Buying | Net Selling |
| AGEN | AGENUS INC | United States | $155.42M | 20,946,004 | 63.15% | 36.85% | Net Buying | Net Buying |
| BPTH | BIO-PATH HOLDINGS INC | United States | $1.69M | 678,795 | 3.24% | 96.76% | ||
| LIFE | ATYR PHARMA INC | United States | $108.40M | 67,750,024 | 60.86% | 22.55% | Net Buying | Net Selling |
| BIOL | BIOLASE INC | United States | $4.68M | 32,522,593 | 0.92% | 56.96% | ||
| GOEV | CANOO INC | United States | $186.75M | 64,397,326 | 44.63% | 55.37% | Net Buying | Net Selling |
| KZR | KEZAR LIFE SCIENCES INC | United States | $58.31M | 72,801,359 | 67.83% | 21.82% | Net Buying | |
| CKPT | CHECKPOINT THERAPEUTICS INC | United States | $51.39M | 35,686,279 | 13.69% | 8.02% | Net Selling | Net Selling |
| OCUP | OCUPHIRE PHARMA INC | United States | $37.96M | 24,813,370 | 1.23% | 98.77% | Net Buying | Net Buying |
| BNED | BARNES & NOBLE EDUCATION INC | United States | $11.00M | 53,156,369 | 22.27% | 77.73% | Net Selling | |
| APTO | APTOSE BIOSCIENCES INC | Canada | $19.18M | 15,717,701 | 7.58% | 67.78% | Net Buying | |
| APLM | APOLLOMICS INC | United States | $41.17M | 89,495,790 | 9.89% | 0.00% | ||
| GOSS | GOSSAMER BIO INC | United States | $159.71M | 225,582,250 | 86.47% | 13.53% | Net Buying | Net Selling |
| AADI | AADI BIOSCIENCE INC | United States | $43.71M | 24,554,205 | 26.99% | 73.01% | Net Selling | Net Selling |
| SONN | SONNET BIOTHERAPEUTICS HOLDINGS INC | United States | $5.66M | 3,069,516 | 1.86% | 98.14% | Net Buying | |
| EVA | ENVIVA INC | United States | $33.52M | 74,496,537 | 27.69% | 72.31% | Net Selling | Net Selling |
| MVST | MICROVAST HOLDINGS INC | United States | $142.74M | 317,206,095 | 20.63% | 31.20% | Net Selling | |
| IFRX | INFLARX NV | Germany | $80.08M | 58,883,272 | 29.00% | 0.00% | ||
| YTEN | YIELD10 BIOSCIENCE INC | United States | $3.60M | 15,401,706 | 2.09% | 97.91% | Net Buying | Net Buying |
| TARA | PROTARA THERAPEUTICS INC | United States | $32.24M | 11,433,837 | 11.95% | 88.05% | Net Selling | |
| VIRX | VIRACTA THERAPEUTICS INC | United States | $32.83M | 39,272,434 | 3.63% | 96.37% | Net Buying | Net Selling |
| MRNS | MARINUS PHARMACEUTICALS INC | United States | $78.69M | 54,642,580 | 81.93% | 18.07% | Net Buying | Net Buying |
| MIST | MILESTONE PHARMACEUTICALS INC | Canada | $88.23M | 53,149,778 | 33.44% | 24.16% | ||
| GNLX | GENELUX CORP | United States | $92.69M | 26,865,473 | 21.54% | 5.21% | Net Selling | Net Selling |
| IMRX | IMMUNEERING CORP | United States | $43.92M | 29,283,272 | 53.75% | 46.25% | Net Selling | Net Selling |
| GEVO | GEVO INC | United States | $159.69M | 240,499,833 | 35.11% | 10.95% | Net Selling | |
| FEMY | FEMASYS INC | United States | $29.39M | 22,099,347 | 6.42% | 8.05% | ||
| INAB | IN8BIO INC | United States | $45.88M | 43,287,325 | 19.83% | 52.04% | Net Buying | |
| SYBX | SYNLOGIC INC | United States | $21.78M | 11,646,977 | 3.98% | 96.02% | Net Selling | Net Selling |
| CVKD | CADRENAL THERAPEUTICS INC | United States | $6.85M | 16,008,469 | 3.45% | 46.72% | Net Buying | |
| NTBL | NOTABLE LABS LTD | Israel | $8.85M | 9,018,261 | 2.63% | 97.37% | Net Selling | |
| MBRX | MOLECULIN BIOTECH INC | United States | $9.69M | 2,227,516 | 45.78% | 54.22% | Net Buying | |
| SGMT | SAGIMET BIOSCIENCES INC | United States | $133.08M | 31,913,887 | 39.98% | 60.02% | Net Buying | Net Buying |
| LUMO | LUMOS PHARMA INC | United States | $22.66M | 8,107,121 | 17.70% | 82.30% | Net Buying | Net Buying |
| VOR | VOR BIOPHARMA INC | United States | $118.61M | 68,168,771 | 87.43% | 10.18% | Net Selling | Net Selling |
| PRST | PRESTO AUTOMATION INC | United States | $13.65M | 80,791,967 | 8.56% | 68.69% | Net Buying | |
| SPRB | SPRUCE BIOSCIENCES INC | United States | $28.89M | 41,149,160 | 63.59% | 36.41% | Net Selling | Net Selling |
| PASG | PASSAGE BIO INC | United States | $68.94M | 55,598,796 | 43.60% | 56.40% | Net Buying | Net Selling |
| GRTS | GRITSTONE BIO INC | United States | $79.73M | 98,065,594 | 42.92% | 22.23% | Net Buying | |
| LUXH | LUXURBAN HOTELS INC | United States | $39.72M | 41,814,361 | 7.28% | 85.94% | Net Buying | |
| IKNA | IKENA ONCOLOGY INC | United States | $62.25M | 48,258,111 | 66.60% | 18.22% | ||
| TPST | TEMPEST THERAPEUTICS INC | United States | $76.34M | 22,192,026 | 4.15% | 95.85% | ||
| PSTX | POSEIDA THERAPEUTICS INC | United States | $199.73M | 96,489,127 | 46.85% | 40.59% | Net Selling | Net Selling |
| PGEN | PRECIGEN INC | United States | $353.47M | 248,919,096 | 25.15% | 73.06% | Net Buying | Net Selling |
| FBIO | FORTRESS BIOTECH INC | United States | $34.43M | 19,234,526 | 24.35% | 62.68% | Net Buying | Net Buying |
| IVA | INVENTIVA SA | France | $168.86M | 52,115,807 | 9.33% | 0.00% | ||
| CARA | CARA THERAPEUTICS INC | United States | $36.73M | 54,656,413 | 44.64% | 53.42% | Net Selling | Net Selling |
| CMPS | COMPASS PATHWAYS PLC | United Kingdom | $520.24M | 64,227,371 | 35.78% | 53.62% | Net Selling | Net Selling |
| AMPX | AMPRIUS TECHNOLOGIES INC | United States | $151.14M | 91,597,817 | 4.85% | 78.15% | Net Selling | Net Buying |
| HOOK | HOOKIPA PHARMA INC | United States | $84.11M | 98,950,107 | 35.22% | 26.83% | Net Buying | |
| CLRB | CELLECTAR BIOSCIENCES INC | United States | $98.72M | 32,260,510 | 26.67% | 12.70% | ||
| OTLK | OUTLOOK THERAPEUTICS INC | United States | $106.71M | 13,012,876 | 13.26% | 86.74% | Net Buying | Net Buying |
| EOSE | EOS ENERGY ENTERPRISES INC | United States | $154.01M | 202,645,716 | 46.82% | 14.22% | Net Selling | Net Selling |
| AQMS | AQUA METALS INC | United States | $53.96M | 111,953,875 | 17.59% | 15.42% | Net Selling | |
| UBX | UNITY BIOTECHNOLOGY INC | United States | $24.68M | 16,786,647 | 25.70% | 51.52% | Net Selling | Net Selling |
| CMPX | COMPASS THERAPEUTICS INC | United States | $203.63M | 137,589,171 | 62.59% | 12.24% | Net Buying | Net Selling |
| ACET | ADICET BIO INC | United States | $154.04M | 82,153,984 | 40.62% | 19.50% | Net Buying |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.